Vascular endothelial growth factor expression, angiogenesis, and necrosis in renal cell carcinomas

Virchows Archiv

Volumn 439, Issue 5, 2001, Pages 645-652

  Hemmerlein, Bernhard ^a   Kugler, Alexander ^a   Özisik, Rehyan ^a   Ringert, Rolf Hermann ^a   Radzun, Heinz Joachim ^a   Thelen, Paul ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Microvessel density; Tumor necrosis; VEGF expression

Indexed keywords

GELATINASE A; GELATINASE B; MESSENGER RNA; VASCULOTROPIN;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CANCER GROWTH; CELL DEATH; CELL DENSITY; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MICROVASCULATURE; PERICYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPHEROID CELL; TUMOR NECROSIS; VASCULAR ENDOTHELIUM; VASCULARIZATION;

EID: 0035166258     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004280100464     Document Type: Article

References (31)

1. A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF- B and VEGF
2. Vascular endothelial growth factor (VEGF) mRNA expression in human tumor models of different histologies
3. Tumor interactions with the vas-culature: Angiogenesis and tumor metastasis
4. Quantitation by competitive PCR assay of vascular endothelial growth factor in non-small cell lung carcinomas
5. Angiogenesis in embryos and ischemic diseases
6. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
7. Up-regulation of vascular endothe-lial growth factor expression in a rat glioma is conferred by two distinct hypoxia-driven mechanisms
8. VEGF induces cardiovascular malformation and embryonic lethality
9. Angiogenesis as a prognostic indicator of survival in non-small-cell lung carcinoma: A prospective study
10. Analysis of blood vessel maturation processes during cyclic ovarian angiogenesis
11. Interleukin-6 and TNF alpha production in human renal cell carcinoma
12. Regulation of macrophage production of vascular endothelial growth factor (VEGF) by hypoxia and transforming growth factor beta-1
13. Expression of acute and late-stage inflammatory antigens, c-fms, CSF-1, and human monocytic serine esterase 1, in tumor-associated macrophages of renal cell carcinomas
14. Comparison of microvessel density with tumor associated macrophages in invasive breast carcinoma
15. Vascular endothelial growth factor increases release of gelatinase A and decreases release of tissue inhibitor of me-talloproteinases by microvascular endothelial cells in vitro
16. Necrosis correlates with high vascular density and focal macrophage infiltration in invasive carcinoma of the breast
17. Cytokine regulation of angiogenesis in breast cancer: The role of tumor- associated macrophages
18. VEGF deprivation-induced apoptosis is a component of programmed capillary regression
19. Vascular endothelial growth factor
20. Development and differentiation of endothelium
21. Angiogenesis, vascular endothelial growth factor and the endometrium
22. Quantification by competitive quantitative RT-PCR of VEGF121 and VEGF165 in renal cell carcinoma
23. Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas). The basic cytological and histopathological elements and their use for diagnostics
24. Necrogenesis and Fas/APO-1 (CD95) expression in primary (de novo) and secondary glioblastomas
25. Mapping of the vascular endothelial growth factor-producing hypoxic cells in multicellular tumor spheroids using a hypoxia-specific marker
26. Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells: Role of flt-1
27. Intratumoral vascularity as a prognostic factor in cancers of the urogenital tract
28. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma
29. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma
30. Vascular architecture and hypoxic profiles in human head and neck squamous cell carcinomas
31. SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages